Add to Calendar 8/26/2020 8:00:00 AM 8/27/2020 5:00:00 PM 2020 State of Possible Conference

Special thanks to our Platinum Sponsor Morgan Stanley

Registered attendees will receive an email with the subject line “Welcome to the State of Possible Conference 2020 - Event Access Link” from

The State of Possible Conference, MassBio's Annual Meeting, will now be hosted virtually on August 26-27, 2020. Featuring interactive networking and a groundbreaking viewer experience, this event will not be your average webinar.  

We will celebrate what’s possible in our industry and for patients today that wasn’t five or 10 years ago. The two-day event will draw over 600 industry leaders from Massachusetts and beyond to debate the most pressing challenges facing the life sciences to ensure we can continue this incredible success. Attendees will hear from the brightest minds through keynotes, panel discussions and 15-minute Possible Talks®, inspiring and engaging content in the style of a TED Talk.

"It's the Woodstock of Life Sciences, with all-star performers playing their greatest hits all on one stage.” – 2019 State of Possible Conference attendee
If you haven’t attended our State of Possible Conference before, it is the premier east coast life sciences conference. We have some of the brightest names in biotech talking about the issues impacting our industry, covering topics from the realities of precision medicine to advancing new drug targets faster.

To inquire about sponsorship opportunities, contact Laura Rudberg.

2020 State of Possible Conference Refund Policy

NOTE: MassBio makes every effort to accommodate our entire community at each of our events. Please let us know at least 3 days in advance of the event if you require special accommodations, such as captioning.
Online Conference, Link will be sent in advance of the event.
Executive Chairman, Biotech NewCo and Strategic Advisor, 5AM Ventures; Board of Directors, uniQure
Paula Soteropoulos is an executive leader with more than 30 years of experience in the biopharm industry in areas of drug development, manufacturing, business development, global commercialization and company building. Paula is a strategic advisor to 5AM Ventures and serves as the Executive Chairman of a 5AM Ventures NewCo. She also serves on the board of directors of uniQure, a leader in gene therapy and most recently served as the CEO and a member of the board of directors of rare disease therapeutic developer Akcea Therapeutics. Paula was the founding President and CEO in 2015 and led the company through its IPO on NASDAQ in 2017, as well as significant growth: employing over 270 staff in thirteen countries, six drugs in its portfolio with 2 rare disease drug approvals. Under Paula’s tenure, Akcea was named by the Boston Business Journal as Massachusetts’ fastest growing public company in 2017 and one of the top stock performers in Massachusetts in 2018 and named one of Massachusetts’ Top 100 Women-Led Businesses in 2016, 2017, 2018 and Top 20 in 2019. Prior, Paula served as Senior Vice President and General Manager, Cardiometabolic Business and Strategic Alliances at Moderna Therapeutics and worked for over 20 years at Genzyme Corporation, most recently as Vice President and General Manager, Cardiovascular, Rare Diseases. She also serves on the Advisory Board of the Tufts University Chemical and Biological Engineering Department. Paula has been involved with a number of initiatives to support the development of female leadership in business, including the Healthcare Business Women’s Association and Women Unlimited. Paula has B.S. and Master’s degrees in Chemical and Biochemical Engineering from Tufts University and an executive management certificate from the Darden School of Business, University of Virginia.

Brought to you by